byiShook Opinion
Jan 13, 2025 - 14:25
Regeneron stock fell slightly Monday after the drugmaker preannounced light sales of a high-dose version of eye drug Eylea. The post Regeneron Culls Losses After High-Dose Eylea Sales Disappoint appeared first on Investor's Business Daily.
Regeneron stock fell slightly Monday after the drugmaker preannounced light sales of a high-dose version of eye drug Eylea.
The post Regeneron Culls Losses After High-Dose Eylea Sales Disappoint appeared first on Investor's Business Daily.